Hematopoietic cell transplantation for myeloid/NK cell precursor acute leukemia in second remission.

Yusuke NoguchiDaisuke TomizawaHaruka HirokiSatoshi MiyamotoMari TezukaReiji MiyawakiMari Tanaka-KubotaTubasa OkanoChika KobayashiNoriko MitsuikiYuki AokiKohsuke ImaiMichiko KajiwaraHirokazu KaneganeTomohiro MorioMasatoshi Takagi

Published in: Clinical case reports (2018)

Myeloid/natural killer cell precursor acute leukemia (MNKPL) is a rare leukemia subtype characterized by a high incidence of extramedullary infiltration. No appropriate treatment strategy has so far been developed. Acute myelogenous leukemia-type chemotherapy combined with L-Asparaginase is an effective treatment for MNKPL. Hematopoietic cell transplantation is a second option in refractory cases.

Keyphrases

bone marrow
acute myeloid leukemia
nk cells
dendritic cells
risk factors
liver failure
single cell
intensive care unit
hepatitis b virus
combination therapy
drug induced
rectal cancer
smoking cessation